Kalb Michael Wayne
Executive Vice President & CFO
Officer
Latest Insider Transactions
5 transactions (past 365 days)
| 2026-01-06 | 2026-01-05 | CPRX Catalyst Pharmaceuticals, Inc. | CFO | Exercise Conversion | 7,139 | $0.00 | $0 |
| 2026-01-06 | 2026-01-05 | CPRX Catalyst Pharmaceuticals, Inc. | CFO | Tax Payment | 2,080 | $0.00 | $0 |
| 2025-11-24 | 2025-11-21 | CPRX Catalyst Pharmaceuticals, Inc. | CFO | Exercise Conversion | 6,894 | $0.00 | $0 |
| 2025-11-24 | 2025-11-21 | CPRX Catalyst Pharmaceuticals, Inc. | CFO | Tax Payment | 2,485 | $0.00 | $0 |
| 2025-11-24 | 2025-11-20 | CPRX Catalyst Pharmaceuticals, Inc. | CFO | Award | 131,536 | $0.00 | $0 |
CPRX
CFO
Exercise Conversion
$0
7,139 shares @ $0.00
Filed 2026-01-06Trade 2026-01-05
Catalyst Pharmaceuticals, Inc.CPRX
CFO
Tax Payment
$0
2,080 shares @ $0.00
Filed 2026-01-06Trade 2026-01-05
Catalyst Pharmaceuticals, Inc.CPRX
CFO
Exercise Conversion
$0
6,894 shares @ $0.00
Filed 2025-11-24Trade 2025-11-21
Catalyst Pharmaceuticals, Inc.CPRX
CFO
Tax Payment
$0
2,485 shares @ $0.00
Filed 2025-11-24Trade 2025-11-21
Catalyst Pharmaceuticals, Inc.